Abstract: The present disclosure relates to multifunctional binding proteins comprising a first and a second antigen binding domains (ABDs) and all or part of an immunoglobulin Fc region or variant thereof, wherein the first ABD binds specifically to human BCMA and the second ABD binds specifically to human NKp46 and wherein all or part of the immunoglobulin Fc region or variant thereof bind to a human Fc-? receptor. The disclosure also relates to methods for making said binding proteins, compositions thereof, and their uses, including the treatment or prevention of proliferative disorders, including multiple myeloma (MM).
| # | Name | Date |
|---|---|---|
| 1 | 202417101485-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [20-12-2024(online)].pdf | 2024-12-20 |
| 2 | 202417101485-STATEMENT OF UNDERTAKING (FORM 3) [20-12-2024(online)].pdf | 2024-12-20 |
| 3 | 202417101485-REQUEST FOR EXAMINATION (FORM-18) [20-12-2024(online)].pdf | 2024-12-20 |
| 4 | 202417101485-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [20-12-2024(online)].pdf | 2024-12-20 |
| 5 | 202417101485-FORM 18 [20-12-2024(online)].pdf | 2024-12-20 |
| 6 | 202417101485-FORM 1 [20-12-2024(online)].pdf | 2024-12-20 |
| 7 | 202417101485-DRAWINGS [20-12-2024(online)].pdf | 2024-12-20 |
| 8 | 202417101485-DECLARATION OF INVENTORSHIP (FORM 5) [20-12-2024(online)].pdf | 2024-12-20 |
| 9 | 202417101485-COMPLETE SPECIFICATION [20-12-2024(online)].pdf | 2024-12-20 |
| 10 | 202417101485-Proof of Right [05-02-2025(online)].pdf | 2025-02-05 |
| 11 | 202417101485-FORM-26 [05-02-2025(online)].pdf | 2025-02-05 |
| 12 | 202417101485-FORM 3 [11-04-2025(online)].pdf | 2025-04-11 |